The Breast Cancer Research Foundation

Call Website

The Breast Cancer Research Foundation We are the highest-rated breast cancer organization in the U.S. We fund research to find a cure for breast cancer in our lifetime.

The Breast Cancer Research Foundation (BCRF) is the largest private funder of breast cancer research—and metastatic breast cancer research—worldwide and is the highest-rated breast cancer research organization in the U.S.

10/14/2026

This year marks the 15th annual Delta Air Lines Breast Cancer One Charter. Delta survivors and thrivers came together for an event filled with connection, celebration, and care as they flew from Atlanta to Las Vegas—and we were honored to be a part of it.

Huge thanks to our amazing partners and supporters for making this day extra special: Ann Taylor, Haven Well Within, LOFT, Soma Intimates, Lane Bryant, Ulta Beauty, CAKES body, Estée Lauder, gorjana, Yves Delmore Paris, and Bombas.

Together, we’re fueling lifesaving research and moving closer to a world without breast cancer.

Photo credit: Chris Rank and Lyndon Eugene

Metastatic breast cancer (MBC) remains incurable—but research is changing what’s possible.As the world’s largest private...
10/14/2026

Metastatic breast cancer (MBC) remains incurable—but research is changing what’s possible.

As the world’s largest private funder of MBC research, BCRF is investing in the science needed to understand how and why breast cancer spreads. Researchers are also working to develop new treatments and ultimately prevent metastasis.

This year, BCRF is investing $23.8 million across 102 projects focused on metastatic breast cancer.

For the estimated 170,000 people living with MBC in the U.S., and for those who may face a diagnosis in the future, every discovery matters.

Learn more about metastatic breast cancer and how BCRF is fueling progress every day at the link in comments.

This Metastatic Breast Cancer Day, we’re shining a light on the realities of MBC—and the research moving us forward.Whil...
10/13/2026

This Metastatic Breast Cancer Day, we’re shining a light on the realities of MBC—and the research moving us forward.

While metastatic breast cancer (MBC), or stage 4, remains incurable, research is changing what's possible.

The Breast Cancer Research Foundation is the world’s largest private funder of metastatic breast cancer research, dedicating $23.8 million to fuel stage 4, and supporting scientists working to understand how cancer spreads, uncover new treatment targets, overcome resistance, and ultimately prevent metastasis.

Every discovery brings us closer to the cures we need. Learn more at the link in comments.

10/13/2026

At 33, Christina was diagnosed with stage 4 metastatic breast cancer after pushing to be heard by four different doctors.

Her story is a powerful reminder that breast cancer can affect anyone—and that research can change what’s possible for people living with metastatic disease.

This Metastatic Breast Cancer Day, help advance the research that can create more options and better treatments for people like Christina.

Join us in fueling the science that gives people with MBC more time at bcrf.org/donate. Right now, in honor of Metastatic Breast Cancer Awareness Day, your gift is 3X MATCHED for TRIPLE the impact.

As the world’s largest private funder of metastatic breast cancer (MBC) research, BCRF recognizes the urgent need to fin...
10/12/2026

As the world’s largest private funder of metastatic breast cancer (MBC) research, BCRF recognizes the urgent need to find the cures patients are waiting for. For those living with MBC and those who will face an MBC diagnosis in the future, we're committed to driving breakthroughs that will end it's life-threatening grasp.

This year, we're devoting $23.8 million across 102 projects to metastatic breast cancer.

Learn more about metastatic breast cancer and how BCRF is fueling progress in this crucial area at the link in comments.

10/12/2026

At just 33 years old, Christina received a stage 4, metastatic, breast cancer diagnosis—eight years ago.

Research has helped create more treatment options—and BCRF-funded scientists are working to find even more.

Your support makes this work possible. For a limited time, your gift will be 3X matched to help give people with breast cancer longer, healthier lives.

Take action now at BCRF.org/donate and triple your impact in supporting lifesaving breast cancer research.

The FDA recently approved a maintenance treatment combination for people with HER2-positive metastatic breast cancer. Th...
10/09/2026

The FDA recently approved a maintenance treatment combination for people with HER2-positive metastatic breast cancer.

The news comes after results from the HER2CLIMB-05 trial, of which BCRF researcher Dr. Nancy U. Lin was a lead investigator. While more research is needed to understand its impact on overall survival, these findings represent progress.

As the world’s largest private funder of metastatic breast cancer research, BCRF supports discoveries that bring us closer to better outcomes and a world free from breast cancer.

Learn more at the link in comments.

Metastatic breast cancer (MBC), also known as stage 4, remains a complex challenge in oncology. But advances in research...
10/09/2026

Metastatic breast cancer (MBC), also known as stage 4, remains a complex challenge in oncology. But advances in research are changing what’s possible for people living with the disease.
Join us Monday, October 19 at 12 p.m. ET for a free virtual panel, “Metastatic Breast Cancer Treatments: A New Era.”

Hear from BCRF investigator Dr. Komal Jhaveri of Memorial Sloan Kettering Cancer Center, and Sally Wolf, MBC thriver, in a conversation moderated by BCRF’s Sadia Haque Zapp. Together, they’ll discuss the latest in cutting-edge treatments, what emerging research means for patients today, and address the questions the MBC community is asking now.

BCRF is the largest private funder of metastatic breast cancer research worldwide, and this year we've dedicated $23.8 million to metastatic breast cancer research.

Sign up for free here: https://us06web.zoom.us/webinar/register/2417890481522/WN__7H0HcUGTKaawI1XpV_IsA #/registration

10/07/2026

For Patricia Robinson, Breast Cancer Awareness Month is personal.

After her breast cancer diagnosis, Patricia found hope in knowing that research is working to better understand breast cancer disparities and improve outcomes for Black women.

Through BCRF’s Health Equity Initiative, researchers are working to uncover answers—and create a future where every woman has a better chance at surviving breast cancer.

10/06/2026

For Debbie LaMotta, supporting breast cancer research is deeply personal.

Diagnosed while raising three young children, Debbie found strength through her family's support—and today, she’s grateful for the 11 years since her diagnosis.

Since 2021, Debbie and her DOWC colleagues have fundraised for BCRF through raffles, bake sales, merchandise, and team events, raising more than $60,000 for breast cancer research.

“I believe research is the only way we can ultimately abolish this disease completely,” Debbie says.

We’re incredibly grateful to her and the entire DOWC team for turning a personal journey into a commitment to advancing research.

Address

New York, NY

Alerts

Be the first to know and let us send you an email when The Breast Cancer Research Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share